INR 19.07
(0.37%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -17.14 Million | 28.04 Million | 9.62 Million | -42.79 Million | 2.86 Million |
Net Income | -17.92 Million | 963 Thousand | 759 Thousand | -8.77 Million | 2.17 Million |
Depreciation & Amortization | 48 Thousand | 21 Thousand | 4000.00 | 7000.00 | 16 Thousand |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 2.37 Million | 28.35 Million | 9.08 Million | -40.49 Million | 234 Thousand |
Other non-cash items | -2.07 Million | -404 Thousand | -224 Thousand | 6.47 Million | 437 Thousand |
Investing Cash Flow | 13 Thousand | -140 Thousand | -2000.00 | 2000.00 | -17 Thousand |
Investments in PPE | - | -145 Thousand | -3000.00 | - | -22 Thousand |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | 13 Thousand | 5000.00 | 1000.00 | 2000.00 | 5000.00 |
Financing Cash Flow | 15.93 Million | -26.23 Million | -9.94 Million | 39.16 Million | 1.36 Million |
Debt repayment | -15.93 Million | -26.23 Million | -9.94 Million | - | -13.83 Million |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | 15.93 Million | -26.23 Million | -9.94 Million | 39.16 Million | 1.36 Million |
Accounts receivables | - | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | 2.79 Million | 27.46 Million | 9.08 Million | -40.49 Million | 234 Thousand |
Cash at beginning of period | 2.03 Million | 365 Thousand | 686 Thousand | 4.31 Million | 104 Thousand |
Cash at end of period | 834 Thousand | 2.03 Million | 365 Thousand | 686 Thousand | 4.31 Million |
Capital Expenditure | - | -145 Thousand | -3000.00 | - | -22 Thousand |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -1.19 Million | 1.66 Million | -321 Thousand | -3.62 Million | 4.21 Million |
Free Cash Flow | -17.14 Million | 27.9 Million | 9.62 Million | -42.79 Million | 2.84 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 197 Thousand | -19.86 Million | -17.92 Million | 705 Thousand | 1.01 Million | 215 Thousand |
Depreciation & Amortization | - | - | 48 Thousand | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 2.37 Million | - | - | - |
Other non-cash items | -197 Thousand | 19.86 Million | -2.07 Million | -705 Thousand | -1.01 Million | -215 Thousand |
Investing Cash Flow | - | - | 13 Thousand | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 13 Thousand | - | - | - |
Financing Cash Flow | - | - | 15.93 Million | - | - | - |
Debt repayment | - | - | -15.93 Million | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 15.93 Million | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 2.79 Million | - | - | - |
Cash at beginning of period | - | - | 2.03 Million | - | - | - |
Cash at end of period | - | - | 834 Thousand | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -1.19 Million | - | - | - |
Free Cash Flow | - | - | -17.14 Million | - | - | - |
JZCP
IMTL
300299
MLNOV
KREBSBIO
002688